Felipe
Casanueva Freijo
Pfizer (United States)
Nueva York, Estados UnidosPublicacións en colaboración con investigadores/as de Pfizer (United States) (3)
2009
-
Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH
European Journal of Endocrinology, Vol. 161, Núm. 4, pp. 533-540
2006
-
Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life?
European Journal of Endocrinology, Vol. 155, Núm. 1, pp. 109-119
2005
-
Traumatic brain injury as a relevant cause of growth hormone deficiency in adults: A KIMS-based study
Archives of Physical Medicine and Rehabilitation, Vol. 86, Núm. 3, pp. 463-468